- Conditions
- Hiv
- Interventions
- Cabotegravir Injection [Apretude]
- Drug
- Lead sponsor
- Midway Specialty Care Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 100 participants
- Timeline
- 2024 – 2027
- U.S. locations
- 3
- States / cities
- Orlando, Florida • Temple Terrace, Florida • West Palm Beach, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV, HIV 1 Infection
- Interventions
- Bictegravir, emtricitabine, and tenofovir alafenamide
- Drug
- Lead sponsor
- CAN Community Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 10
- States / cities
- Clearwater, Florida • Ft. Pierce, Florida • Jacksonville, Florida + 6 more
- Conditions
- Hiv, HIV-1-infection, HIV Infections
- Interventions
- DTG/3TC versus BIC/F/TAF
- Drug
- Lead sponsor
- Midway Specialty Care Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- West Palm Beach, Florida